BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12730352)

  • 1. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.
    Deseure K; Koek W; Adriaensen H; Colpaert FC
    J Pharmacol Exp Ther; 2003 Aug; 306(2):505-14. PubMed ID: 12730352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
    Deseure K; Bréand S; Colpaert FC
    Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
    Colpaert FC; Deseure K; Stinus L; Adriaensen H
    J Pharmacol Exp Ther; 2006 Feb; 316(2):892-9. PubMed ID: 16254131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
    Colpaert FC; Wu WP; Hao JX; Royer I; Sautel F; Wiesenfeld-Hallin Z; Xu XJ
    Eur J Pharmacol; 2004 Aug; 497(1):29-33. PubMed ID: 15321732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain.
    Deseure KR; Adriaensen HF; Colpaert FC
    Eur J Pain; 2004 Dec; 8(6):547-54. PubMed ID: 15531223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
    Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain.
    Deseure K; Koek W; Colpaert FC; Adriaensen H
    Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
    Colpaert FC
    Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury.
    Wu WP; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Koek W; Colpaert FC
    Eur J Pharmacol; 2003 Oct; 478(2-3):131-7. PubMed ID: 14575797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
    Kiss I; Degryse AD; Bardin L; Gomez de Segura IA; Colpaert FC
    Eur J Pharmacol; 2005 Oct; 523(1-3):29-39. PubMed ID: 16226246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour.
    Idänpään-Heikkilä JJ; Guilbaud G
    Pain; 1999 Feb; 79(2-3):281-90. PubMed ID: 10068174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
    Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
    Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury.
    Hao JX; Stöhr T; Selve N; Wiesenfeld-Hallin Z; Xu XJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):135-40. PubMed ID: 17092498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Nakai K; Nakae A; Oba S; Mashimo T; Ueda K
    Eur J Pain; 2010 Nov; 14(10):999-1006. PubMed ID: 20488736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study.
    Buritova J; Larrue S; Aliaga M; Besson JM; Colpaert F
    Eur J Pharmacol; 2005 May; 514(2-3):121-30. PubMed ID: 15910798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
    Bruins Slot LA; Koek W; Tarayre JP; Colpaert FC
    Eur J Pharmacol; 2003 Apr; 466(3):271-9. PubMed ID: 12694810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin ET(B) receptor antagonist reduces mechanical allodynia in rats with trigeminal neuropathic pain.
    Chichorro JG; Zampronio AR; Rae GA
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1136-40. PubMed ID: 16741064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.